Maaskant R A, Bogic L V, Gilger S, Kelly P A, Bryant-Greenwood G D
Pacific Biomedical Research Center, University of Hawaii, Honolulu 96822, USA.
J Clin Endocrinol Metab. 1996 Jan;81(1):396-405. doi: 10.1210/jcem.81.1.8550784.
Human PRL is synthesized and secreted by the maternal decidua, but not by the chorionic cytotrophoblast of the chorion laeve or the placenta. The sites of action for decidual PRL are currently unknown. Accordingly, Northern analysis and in situ hybridization histochemistry have been used respectively to quantitate and localize the expression of the PRL receptor (PRL-R) gene within the uterus during the peripartal period. Immunocytochemistry and Western blot analysis using an anti-PRL-R antibody (U5) localized the translated protein at the cellular level in the same tissues. As judged by the level of expression of the PRL-R gene and its translated products, the chorionic cytotrophoblast has been shown to be a primary site of action. Novel sites were also shown in the decidua, placental trophoblast, and amniotic epithelium. In situ hybridization was not obtained in the latter despite positive Northern analysis and immunostaining. Western analyses with an antibody (U5) to the extracellular domain of the rat PRL-R detected six major molecular species of 95, 85, 63, less than 63, more than 30, and 30 kDa in cytosol from separated amnion, chorion, and decidua. The two bands at 95 and 85 kDa were approximate values only and represent the mature glycosylated forms of the human PRL-R. The other four major bands were partial degradation products from the PRL-R, showing tissue-specific processing and patient to patient variation related to the spectrum of proteases present in these tissues. The 63- and 30-kDa PRL-R-related proteins were detected in both the cytosol and medium from amnion, chorion, and decidua and were also present in amniotic fluid. The 30-kDa species was equal in size to a recently reported PRL-binding protein in human milk. The release of these two PRL-R-related proteins into amniotic fluid suggests possible functions as binding and or/PRL transport proteins in these tissues. The more than 30-kDa species was detected in high amounts in both cytosol and medium from the decidua, but was absent from amniotic fluid. Further work is required to clarify the structural relationships and potential functions of these immunologically PRL-R-related proteins. This study shows that the PRL-R is widely expressed by both fetal and maternal tissues in late pregnancy. Its increased expression during labor and delivery in the chorion, decidua, and placenta supports an autocrine/paracrine role for decidual PRL in the peripartum.
人催乳素由母体蜕膜合成并分泌,但平滑绒毛膜或胎盘的绒毛膜细胞滋养层不分泌。目前尚不清楚蜕膜催乳素的作用位点。因此,分别采用Northern印迹分析和原位杂交组织化学技术,对围产期子宫内催乳素受体(PRL-R)基因的表达进行定量和定位。使用抗PRL-R抗体(U5)的免疫细胞化学和Western印迹分析在相同组织的细胞水平上定位了翻译后的蛋白质。根据PRL-R基因及其翻译产物的表达水平判断,绒毛膜细胞滋养层已被证明是主要作用位点。在蜕膜、胎盘滋养层和羊膜上皮中也发现了新的作用位点。尽管Northern印迹分析和免疫染色呈阳性,但在后者中未获得原位杂交结果。用针对大鼠PRL-R细胞外结构域的抗体(U5)进行的Western分析在分离的羊膜、绒毛膜和蜕膜的胞质溶胶中检测到六种主要分子形式,分子量分别为95、85、63、小于63、大于30和30 kDa。95和85 kDa处的两条带只是近似值,代表了人PRL-R的成熟糖基化形式。其他四条主要带是PRL-R蛋白的部分降解产物,显示出组织特异性加工以及与这些组织中存在的蛋白酶谱相关的个体差异。在羊膜、绒毛膜和蜕膜的胞质溶胶和培养基中均检测到63 kDa和30 kDa的PRL-R相关蛋白,羊水也中存在。30 kDa的蛋白与最近报道的人乳中PRL结合蛋白大小相同。这两种PRL-R相关蛋白释放到羊水中表明它们在这些组织中可能具有结合和/或PRL转运蛋白的功能。大于30 kDa的蛋白在蜕膜的胞质溶胶和培养基中大量检测到,但羊水中不存在。需要进一步的研究来阐明这些免疫相关的PRL-R蛋白的结构关系和潜在功能。本研究表明,PRL-R在妊娠晚期的胎儿和母体组织中广泛表达。其基因在分娩时绒毛膜、蜕膜和胎盘中的表达增加,支持了蜕膜催乳素在围产期的自分泌/旁分泌作用。